WednesdayNov 04, 2026 10:30 am

Adaptogenics Health Corp. (CSE: ADPT) Eyes Opportunities Beyond Standard Peptides as Policy Opens Pharmacy and Telehealth Channels

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. The federal government is working on an interim peptide access policy that would let specialty pharmacies to produce certain peptides while formal rulemaking proceeds. Adaptogenics plans to develop delivery technologies to improve the stability, exposure, administration and performance of selected peptides. The company has also acquired nutritional research assets developed by Berkwood Research to support a GLP-1 companion initiative. U.S. Health Secretary Robert F. Kennedy Jr. has made his view plain. Americans, he said, are going to buy peptides anyway, so the government should make sure they come…

Continue Reading

WednesdayNov 04, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Broad Strategy Anchored by Science, Disciplined Growth

The scale of the need for neurological solutions is enormous; the World Health Organization reports that more than three billion people live with a neurological condition. Quantum focuses on neurodegenerative, metabolic and alcohol misuse disorders, pursuing a strategy that pairs pharmaceutical research with commercialization partnerships and licensing structures designed to support multiple potential revenue streams. The most advanced piece of the neurodegenerative strategy is Lucid-MS, a patented new chemical entity designed to address demyelination. Brain disorders touch more lives than almost any other area of medicine, yet they remain among the hardest to treat. Quantum BioPharma (NASDAQ: QNTM) is taking on…

Continue Reading

WednesdayNov 04, 2026 9:00 am

MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Digital Asset Infrastructure Beyond Blockchain Security

MindWave is developing an integrated infrastructure model combining digital asset treasury, validator operations, insurance innovation, and real-world asset tokenization. Its MindChain Layer 2 and validator infrastructure are designed to complement technical security with institutional risk management and protection. New agreements to build and operate AssureChain and AQUAEChain demonstrate how MindChain can serve as infrastructure for specialized institutional networks. For institutions entering the digital asset economy, blockchain security is only one part of the risk equation. Audits, validator monitoring, secure custody and infrastructure controls can lower the risk of technical and operational failures, but they do not necessarily address what happens…

Continue Reading

TuesdayNov 03, 2026 10:30 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances Overwatch Integration with European Drone Manufacturer

Disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI has signed an MOU with a European drone manufacturer to integrate and evaluate its Overwatch positioning platform on two fixed-wing unmanned aerial vehicle (“UAV”) platforms. The agreement also incorporates Overwatch Intelligence, designed to consolidate positioning, observation and movement data from connected aircraft into a unified operational view. Following operator-run field trials in Ukraine and the Middle East, SPARC AI is pursuing additional defense and commercial opportunities, including through a new regional advisory agreement. Reliable positioning is becoming an important consideration as autonomous systems expand into environments…

Continue Reading

TuesdayNov 03, 2026 9:45 am

American Fusion(TM) Inc. (AMFN) Reports Four Texatron(TM) Commercial Proposals as Pulsed-Power Testing Advances

Four commercial proposals for potential Texatron(TM) fusion program deployments remain under active discussion. The company is pursuing discussions with data center developers as it explores a model in which it would own and operate future Texatron(TM) systems and sell electricity under long-term agreements. American Fusion(TM) has upgraded electrical switching equipment and configured higher-capacity capacitor banks for the next phase of Texatron(TM) pulsed-power experiments. A technical manuscript prepared by Chief Technology Officer Dr. John E. Brandenburg is undergoing scientific review, with publication and public release planned after the formal process is completed. American Fusion(TM) (OTCBQ: AMFN), developer of next-generation fusion energy…

Continue Reading

TuesdayNov 03, 2026 9:00 am

Earth Science Tech Inc. (ETST) Wins Through the Inherent Operating Leverage of Its ‘Conglomerate’ Business Model

Earth Science Tech’s ‘conglomerate’ business model has allowed it to leverage its internal tech stack, real estate, as well as ingredient-sourcing and manufacturing capabilities to capture the profit margins at every step that other companies are forced to outsource The company is focused on building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment Earth Science Tech now augments its healthcare operations through investments in real estate, asset management activities, and consumer products business Earth Science Tech (OTCQB: ETST) is a strategic holding company that brings together innovative businesses across the healthcare,…

Continue Reading

MondayNov 02, 2026 11:15 am

Adaptogenics Health Corp. (CSE: ADPT) Targets Supply, Verification, Traceability in Emerging Peptide Market

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. The movement toward a regulated peptide market is increasing its momentum. A responsible peptide market needs four things: dependable supply, documented traceability, independent verification and better products grounded in evidence. Better products are the longer-term goal, and Adaptogenics’ research programs will be built around defined biological endpoints and development milestones. Peptides are moving from the fringes of wellness culture toward the regulated pharmacy counter. Whether that shift protects patients will depend on something less visible than policy: proof of what is actually in each vial. Adaptogenics Health (CSE:…

Continue Reading

MondayNov 02, 2026 10:30 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) Draws ‘Men’s Fitness’ Spotlight as Unbuzzd Trial Shows Early Promise

Earlier this month, “Men’s Fitness,” reviewed the unbuzzd clinical trial and described the early study findings as “promising.” Results showed that estimated blood alcohol concentration was significantly lower and participants experienced improved self-rated alertness and lower headache severity. For operators in this space, the stakes reach beyond the morning after. Most recovery drinks promise relief after a night out, yet few have been tested against a placebo in a registered human trial. One that has is now getting a close look from a major fitness publication. Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company developing therapies for neurodegenerative, metabolic and alcohol misuse disorders,…

Continue Reading

MondayNov 02, 2026 9:45 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Positions Proprietary Platform as Software Answer to GPS Denial, Presents Solution at Annual Expo

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. The U.S. Army is requesting information aimed at fielding resilient positioning across every unit and operational domain, specifically because GPS signals coded for military use are now denied in contested environments. SPARC’s flagship product, Overwatch, is described as a GPS-denied positioning and targeting network for uncrewed systems. The company sponsored the Ukrainian Defense Tech Pavilion Reception at the Association of the United States Army’s 2026 Annual Meeting and Exposition. Satellite navigation used to be something militaries could count on without a second thought. That assumption is…

Continue Reading

MondayNov 02, 2026 9:00 am

Beyond Defense Applications: The Non-Military Market Opportunity for Silynxcom Ltd. (NYSE American: SYNX)

Silynxcom hearing protection systems fit a wide range of commercial/civilian use cases for industrial operations, security, sport shooting, and any environments where people need both noise reduction and situational awareness, without the solution being too bulky. These systems are lightweight and ergonomic, rugged, dustproof, waterproof, and compatible with glasses, helmets, and other types of gear users may need to wear. Shooters may spend thousands on their guns, optics, ammunition, and eyewear, yet often protect their hearing with only a few cents’ worth of foam. The same gap between investment and protection shows up wherever people work or train in loud…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered